FDA warns of counterfeit cancer drug
Feb-18-2012

A counterfeit version of the anti-cancer drug Avastin may have been purchased and used in a number of medical facilities in the United States, the U.S. Food and Drug Administration warned Wednesday.
The FDA sent letters to 19 medical practices known to have purchased unapproved cancer medications, according to the agency.
The counterfeit version of Avastin lacks the medicine's key ingredient, bevacizumab.
Roche, the pharmaceutical company that manufactures Avastin, conducted laboratory tests confirming the presence of the counterfeit version, the FDA noted.
"The counterfeit product is not safe or effective and should not be used," Roche member company Genentech said in a written statement. Genentech is responsible for marketing Avastin.

Read the rest of the article by clicking the link below.

Visit Website

Posted by Ken at 12:00 AM - Link to this entry  |  Share this entry  |  Print